RENOVA from OrthoNeutrogena
I'm looking for information
I'm thinking of seeing a doctor
I'm have a RENOVA prescription
dermatologist finder ask us share this page about this company prescribing info
I Have a RENOVA Prescription

Product Information

Click on a topic below to learn about:

If You Have a Prescription for RENOVA
What It Is
Active Ingredient
What to Expect
Possible Side Effects
Precautions
Clinical Studies
Manufacturer/Marketer
Full U.S. Prescribing Information

If You Have a Prescription for RENOVA
Please read this information carefully before you start using RENOVA. This Web site provides a summary of information about RENOVA. It does not include everything there is to know about your medicine. This information does not take the place of talking with your doctor or dermatologist.
Back to Top

What It Is
RENOVA (tretinoin cream) 0.02% is the first prescription approved by the FDA and proven to reduce fine facial wrinkles, including crow's feet, when used as part of a total skin care and sun protection program. RENOVA does not eliminate wrinkles, repair sun-damaged skin, reverse photoaging or restore more youthful or younger skin.
Back to Top

Active Ingredient
RENOVA contains tretinoin, a Vitamin A derivative, like the one naturally occurring in your body (Vitamin A is also an essential nutrient found in yellow and orange vegetables such as carrots and yams). Tretinoin works within the cell and is believed to increase collagen production in the epidermis and decrease collagen breakdown in the dermis to improve the skin's internal structure.
Back to Top

What to Expect
When using RENOVA, you should begin to notice your skin becoming smoother and softer within the first month or two. Within three to four months, you may notice a reduction in fine facial wrinkles. Additional benefits should be apparent within five to six months of therapy.
For more information on what to expect while using RENOVA, click here.
Back to Top

Possible Side Effects
While using RENOVA, you may experience some redness, itching, dryness or peeling because RENOVA is a dermal irritant. This is most often mild and most common when treatment is started. In some patients, this may be severe. When using RENOVA, you should limit exposure to the sun and always use a sunscreen.
Back to Top

Precautions
Patients should avoid preparations that may dry or irritate the skin. If a reaction suggesting sensitivity or chemical irritation occurs, consult a doctor. Talk to your doctor before using over-the-counter products containing benzoyl peroxide with RENOVA. Tretinoin and benzoyl peroxide should not be applied at the same time.

Unprotected exposure to sunlight, including sunlamps, should be minimized and patients with sunburn should be advised not to use the product until fully recovered. Wearing sunscreen is highly recommended. Do not use RENOVA if you are taking drugs known to be photosensitizers, are pregnant, think you are pregnant, trying to get pregnant or are breast-feeding. If you become pregnant while using RENOVA, contact your doctor right away
Back to Top

Clinical Studies
Like other prescription medications, RENOVA 0.02% has been tested for safety and effectiveness. As such, it is proven to reduce fine facial wrinkles when used as part of a comprehensive skin care and sun avoidance program. RENOVA has been proven safe and effective in clinical trials lasting 52 weeks. Effectiveness beyond 52 weeks has not been established in controlled clinical trials.

For more information about RENOVA 0.02%, call 1-800-54-RENOVA (547-3668).
Back to Top

Manufacturer/Marketer
RENOVA is marketed by OrthoNeutrogena.
Back to Top

Full U.S. Prescribing Information
You will need the
Adobe Acrobat Reader in order to view the full U.S. Prescribing Information. If you do not already have it, you can download it for free from Adobe's website.
For RENOVA 0.02%
Back to Top

Click here for Frequently Asked Questions. If you have any questions please call us at 1-800-54-RENOVA (1-800-547-3668) or e-mail us

 legal notice privacy policy site map compliance
 ©2003-2008 OrthoNeutrogena, a division of Ortho-McNeil Pharmaceuticals, Inc.
Capitalized product names are trademarks of OrthoNeutrogena.
This site intended for U.S. residents only. Site last updated: 30 April 2008